Stroke, Vol 25, 1836-1841, Copyright © 1994 by American Heart Association
B Elger, J Seega and R Brendel
BACKGROUND AND PURPOSE: Beneficial effects of calcium antagonists in
cerebral ischemia and trauma have been attributed in part to improved
cerebral blood flow. Enhancement of cerebral blood flow, however, could
aggravate the pathological situation if brain injury is associated with
intracerebral hemorrhage. In this study we used high-field magnetic
resonance imaging in an animal model of intracerebral hemorrhage to
determine noninvasively the effect of the calcium and serotonin antagonist
levemopamil [international nonproprietary name for (S)- emopamil] when
infused in a dose (6 mg/kg) that is known to increase cerebral blood flow.
METHODS: Intracerebral hemorrhage was induced in rats by stereotaxic
microinfusion of collagenase into the caudate putamen. Two series of
experiments were performed. (1) Levemopamil was intravenously infused 30
minutes after intracerebral infusion of collagenase (0.05 U), which
represents the time of intracranial bleeding. Another group of animals was
given heparin (55 IU.kg-1.min-1) to evaluate the capability of this animal
model to demonstrate drug- induced worsening of intracerebral hemorrhage.
(2) The effects of hyperacute infusion of levemopamil (30 minutes after
infusion of 0.5 U of collagenase) were compared with those of a 2-hour
delayed administration. In both experimental settings, the extent of
intracerebral hemorrhage was determined by T1-weighted magnetic resonance
images (spin-echo; repetition time, 400 milliseconds; echo time, 23
milliseconds) taken in vivo in a coronal and a transverse brain plane 24
hours after collagenase infusion. RESULTS: (1) Hemorrhagic brain areas
measured 10.1 +/- 2.9 mm2, 8.5 +/- 2.1 mm2, and 18.8 +/- 2.5 mm2 in the
coronal brain plane (10 mm anterior to the interaural line) of control,
levemopamil-, and heparin-infused rats, respectively (8 animals per group,
mean +/- SD). In the transverse brain plane (6 mm dorsal to the interaural
line) the hemorrhagic area was 11.5 +/- 3.6 mm2, 9.7 +/- 2.4 mm2, and 19.9
+/- 3.3 mm2 in control, levemopamil-, and heparin-infused rats,
respectively. (2) Animals with 2-hour delayed levemopamil infusion
displayed intracerebral hemorrhage similar in size to that of control rats.
(3) Neither small nor large hemorrhagic lesions were increased by
levemopamil. CONCLUSIONS: Aggravation of intracerebral hemorrhage was not
observed by magnetic resonance imaging in levemopamil-infused animals.
However, infusion of heparin caused a significant (P < .05), almost
twofold increase in the size of intracerebral hemorrhage. These results
justify clinical trials with levemopamil in cerebral disorders such as
stroke, brain trauma, and peritumoral brain edema, which may be accompanied
by intracerebral hemorrhage from the beginning or where transition to
intracerebral hemorrhage may occur.
ARTICLES
Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats
Knoll AG, Ludwigshafen, Germany.
This article has been cited by other articles:
![]() |
T. F. Choudhri, B. L. Hoh, R. A. Solomon, E. S. Connolly Jr, and D. J. Pinsky Use of a Spectrophotometric Hemoglobin Assay to Objectively Quantify Intracerebral Hemorrhage in Mice Stroke, November 1, 1997; 28(11): 2296 - 2302. [Abstract] [Full Text] |
||||
![]() |
M. R. D. Bigio, H.-J. Yan, R. Buist, J. Peeling, and G. J. del Zoppo Experimental Intracerebral Hemorrhage in Rats: Magnetic Resonance Imaging and Histopathological Correlates Stroke, December 1, 1996; 27(12): 2312 - 2320. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |